Last reviewed · How we verify

NCT06015425

tDCS in Depression in Perinatal Women

Status unknown NA Last updated 31 August 2023
What this trial tests

NA trial testing MINDD STIM+ in Depression in 125 participants. Status unknown.

Timeline
1 October 2023
Primary endpoint
1 March 2024
31 December 2025

Quick facts

Lead sponsorSeoul National University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment125
Start date1 October 2023
Primary completion1 March 2024
Estimated completion31 December 2025
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Seoul National University Hospital

Who can join

Adults 19 to 50, female only, with Depression or Pregnancy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is Real-world data(RWD) collection and Real-world evidence(RWE) clinical demonstration study of Transcranial direct current stimulation(tDCS) for the treatment of depression in perinatal women. Participants will apply tDCS by themselves for 4 weeks at home. Researchers will compare Visit 1 to Visit 3 in one group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

Other Seoul National University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06015425.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing